Recognition of patients who would benefit from LAI antipsychotic treatment: how to assess adherence

The Journal of clinical psychiatry

Volumn 75, Issue 11, 2014, Pages e29-

  Correll, Christoph U ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELAYED RELEASE FORMULATION; NEUROLEPTIC AGENT;

DELAYED RELEASE FORMULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; PSYCHOLOGY; SCHIZOPHRENIA; STANDARDS; THERAPEUTIC USE;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; SCHIZOPHRENIA;

EID: 84927566479     PISSN: None     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13024tx3c     Document Type: Review

References (0)